Aurinia Pharmaceuticals Inc (AUPH)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AUPH? Forum Prognose Aktiensplit

Finanzdaten der Aurinia Pharmaceuticals Inc-Aktie (AUPH)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.96% 77.11	73.47	70.01	62.47	67.77
Cost Of Revenue	7.61% 8.799	8.177	7.115	8.574	6.035
Gross Profit	4.63% 68.31	65.29	62.89	53.89	61.74
Operating Expenses	0.35% 43.88	43.72	49.92	40.62	49.99
Benefits Costs and Expenses	-	-	-	-	52.96
Costs And Expenses	0.35% 43.88	43.72	49.92	40.62	56.02
Operating Income/Loss	11.75% 33.24	29.75	20.08	21.85	11.75
Income/Loss From Continuing Operations Before Tax	141.27% 77.11	31.96	22.16	24.35	14.81
Income Tax Expense/Benefit	42,704% -175.10	0.411	0.643	1.005	0.457
Income/Loss From Continuing Operations After Tax	568.11% 210.79	31.55	21.51	23.34	14.35
Net Income/Loss	568.11% 210.79	31.55	21.51	23.34	14.35
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	100.60% -0.796	131.81	134.87	138.92	143.05
Diluted Average Shares	100.19% -0.259	136.01	137.53	143.20	145.65
Basic Earnings Per Share	566.67% 1.60	0.24	0.16	0.17	0.10
Diluted Earnings Per Share	565.22% 1.53	0.23	0.16	0.16	0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%